• News
  • About the company
  • Investors & Media
  • Research and development
  • Generic Products
  • Join us
  • EN
  • EN
  • News
  • About the company
  • Investors & Media
  • Research and development
  • Generic Products
  • Join us

Our results will be presented at EORTC!

We are happy to present the latest results from our R&D laboratoriries at EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics held on 06-09 November in Dublin.  Our communication is entitled: "Discovery of CPL-407-22 - novel, potent and highly selective JAK2 kinase inhibitor."

Ogrodowa 2A
05-092 Łomianki / Kiełpin

phone: +48 22 751 59 33

e-mail: [email protected]

NIP :118-16-42-061,
REGON : 015181033

Site Map

  • News
  • About the company
  • Requests for Proposals
  • Privacy policy
  • Quality policy
  • Report an adverse effect
  • Manage Cookies

Cookies

Manage cookies

Below, you can manage your preferences regarding cookies on your device in connection with using our website. For more information about personal data processing and your rights, please refer to our Privacy Policy – Celon Pharma.

Cookies used for the proper functioning of the website include, among others, setting privacy preferences, information about the browser, or the player used (e.g., volume). You can set your browser to block such cookies or display appropriate notifications, but some parts of the website may not function properly as a result.